Crosslinkable silane-terminated polymer and sealant composition made with same

Details for Australian Patent Application No. 2006214479 (hide)

Owner Momentive Performance Materials Inc.

Inventors Landon, Shayne J.; Waldman, Bruce A.

Agent Fisher Adams Kelly

Pub. Number AU-B-2006214479

PCT Pub. Number WO2006/088839

Priority 60/655,976 15.02.05 US; 11/292,045 01.12.05 US

Filing date 14 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 8 December 2011

International Classifications

C08G 18/10 (2006.01) Polymeric products of isocyanates or isothiocyanates

C08K 5/54 (2006.01) Use of organic ingredients

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/088839 Priority application(s): WO2006/088839

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

11 February 2010 Section 223 Application Allowed

  General Electric Company the time in which to request examination has been extended to 12 Feb 2010. Address for service in Australia - Fisher Adams Kelly Level 29 12 Creek Street Brisbane QLD 4000

8 December 2011 Application Accepted

  Published as AU-B-2006214479

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214480-Novel heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity

2006214477-Heterocyclic substituted piperazines with CXCR3 antagonist activity